2006Yaowu fenxi zazhiRequires access

HPLC determination of related substances in lorazepam and its tablets

Cheng Dong-sheng, Lei Chen

Open publisher page 0 citations

Abstract

Objective:To determine four related substances simultaneously in lorazepam and its tablets by HPLC. Methods:The separation was performed on a C_(18)column (250mm×4.6mm,5μm),the mobile phase was com- posed of 0.05mol·L~(-1)ammonium dihydrogen orthophosphate methanol-acetonitrile (35:35:30,adjust the solu- tion with 1mol·L~(-1)phosphoric acid to a pH of 3.5),the flow rate was 1.0mL min~(-1)and detection at 240nm. Results:The separations of lorazepam and its impurities was good.For impurity B,the calibration curve was linear in the range of 0.1964~19.64μg·mL~(-1)with correlation coefficient 0.9999 and the regression equation being Y= 51.47317X-3.34831,and the detection limit was 3ng;The recovery of assay was 100.1%,and the RSD was 0.4% (n=4).For impurity C,the calibration curve was linear in the range of 0.202-20.2μg·mL~(-1)with corre- lation coefficient 0.9999 and the regression equation being Y=36.32533X-4.37263,and the detection limit was 0.4 ng;The recovery of assay was 101.4%,and the RSD was 1.7% (n =4).For impurity D,the calibration curve was linear in the range of 0.1992-19.92μg·mL~(-1)with correlation coefficient 0.9994 and the regression equation being Y=70.36881X-2.9103,and the detection limit was 0.58 ng;The recovery of assay was 100.8%,and the RSD was 0.5% (n =4).For impurity E,the calibration curve was linear in the range of 0.188-18.8μg·mL~(-1) with correlation coefficient 0.9997 and the regression equation being Y=54.74563X-1.93471,and the detection limit was 0.73 ng ;The recovery of assay was 103.1% ,and the RSD was 0.7% (n =4).Conclusion:The method is simple,sensitive and it is suitable for the determation of the related substances of lorazepam tablets.

About this research paper

What this paper is about

Objective:To determine four related substances simultaneously in lorazepam and its tablets by HPLC. Methods:The separation was performed on a C_(18)column (250mm×4.6mm,5μm),the mobile phase was com- posed of 0.05mol·L~(-1)ammonium dihydrogen orthophosphate methanol-acetonitrile (35:35:30,adjust the solu- tion with 1mol·L~(-1)phosphoric acid to a pH of 3.5),the flow rate was 1.0mL min~(-1)and detection at 240nm. Results:The separations of lorazepam and its impurities was good.For impurity B,the calibration curve was linear in the range of 0.1964~19.64μg·mL~(-1)with correlation coefficient 0.9999 and the regression equation being Y= 51.47317X-3.34831,and the detection limit was 3ng;The recovery of assay was 100.1%,and the RSD was 0.4% (n=4).For impurity C,the calibration curve was linear in the range of 0.202-20.2μg·mL~(-1)with corre- lation coefficient 0.9999 and the regression equation being Y=36.32533X-4.37263,and the detection limit was 0.4 ng;The recovery of assay was 101.4%,and the RSD was 1.7% (n =4).For impurity D,the calibration curve was linear in the range of 0.1992-19.92μg·mL~(-1)with correlation coefficient 0.9994 and the regression equation being Y=70.36881X-2.9103,and the detection limit was 0.58 ng;The recovery of assay was 100.8%,and the RSD was 0.5% (n =4).For impurity E,the calibration curve was linear in the range of 0.188-18.8μg·mL~(-1) with correlation coefficient 0.9997 and the regression equation being Y=54.74563X-1.93471,and the detection limit was 0.73 ng ;The recovery of assay was 103.1% ,and the RSD was 0.7% (n =4).Conclusion:The method is simple,sensitive and it is suitable for the determation of the related substances of lorazepam tablets.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To determine four related substances simultaneously in lorazepam and its tablets by HPLC. Methods:The separation was performed on a C_(18)column (250mm×4.6mm,5μm),the mobile phase was com- posed of 0.05mol·L~(-1)ammonium dihydrogen orthophosphate methanol-acetonitrile (35:35:30,adjust the solu- tion with 1mol·L~(-1)phosphoric acid to a pH of 3.5),the flow rate was 1.0mL min~(-1)and detection at 240nm. Results:The separations of lorazepam and its impurities was good.For impurity B,the calibration curve was linear in the range of 0.1964~19.64μg·mL~(-1)with correlation coefficient 0.9999 and the regression equation being Y= 51.47317X-3.34831,and the detection limit was 3ng;The recovery of assay was 100.1%,and the RSD was 0.4% (n=4).For impurity C,the calibration curve was linear in the range of 0.202-20.2μg·mL~(-1)with corre- lation coefficient 0.9999 and the regression equation being Y=36.32533X-4.37263,and the detection limit was 0.4 ng;The recovery of assay was 101.4%,and the RSD was 1.7% (n =4).For impurity D,the calibration curve was linear in the range of 0.1992-19.92μg·mL~(-1)with correlation coefficient 0.9994 and the regression equation being Y=70.36881X-2.9103,and the detection limit was 0.58 ng;The recovery of assay was 100.8%,and the RSD was 0.5% (n =4).For impurity E,the calibration curve was linear in the range of 0.188-18.8μg·mL~(-1) with correlation coefficient 0.9997 and the regression equation being Y=54.74563X-1.93471,and the detection limit was 0.73 ng ;The recovery of assay was 103.1% ,and the RSD was 0.7% (n =4).Conclusion:The method is simple,sensitive and it is suitable for the determation of the related substances of lorazepam tablets.

Key concepts: Chemistry, Calibration curve, Chromatography, Detection limit, Correlation coefficient, Phosphoric acid, High-performance liquid chromatography, Impurity

Related papers

Back to paper searchBrowse research topicsOriginal source
HPLC determination of related substances in lorazepam and its tablets — Research Paper | ScholarLens